DIN 02547198 — JAMP CEFUROXIME 250 MG
JAMP CEFUROXIME is a tablet of Cefuroxime marketed by JAMP PHARMA CORPORATION. The full Cefuroxime monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02547198
- Brand name
- JAMP CEFUROXIME
- Active ingredient
- Cefuroxime
- Strength
- 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Second-generation cephalosporin antibiotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cefuroxime products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02244393 | APO-CEFUROXIME | 250 MG | TABLET | APOTEX INC | MARKETED |
| 02244394 | APO-CEFUROXIME | 500 MG | TABLET | APOTEX INC | MARKETED |
| 02344823 | AURO-CEFUROXIME | 250 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02344831 | AURO-CEFUROXIME | 500 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02212307 | CEFTIN | 125 MG | GRANULES FOR SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02241639 | CEFUROXIME FOR INJECTION, USP | 1.5 G | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02422301 | CEFUROXIME FOR INJECTION, USP | 1.5 G | POWDER FOR SOLUTION | HIKMA CANADA LIMITED | DORMANT |
| 02422328 | CEFUROXIME FOR INJECTION, USP | 7.5 G | POWDER FOR SOLUTION | HIKMA CANADA LIMITED | DORMANT |
| 02241638 | CEFUROXIME FOR INJECTION, USP | 750 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02422298 | CEFUROXIME FOR INJECTION, USP | 750 MG | POWDER FOR SOLUTION | HIKMA CANADA LIMITED | DORMANT |
| 02547201 | JAMP CEFUROXIME | 500 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |